Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Interleukin Companies

Dedicated to advancing medical research, IL-10 Pipeline companies focus on developing therapies harnessing the potential of Interleukin-10. These organizations drive progress in treating inflammatory disorders, autoimmune diseases, and beyond, contributing to the evolution of novel pharmaceuticals with the promise of improved patient outcomes.

Interleukin-10 Pipeline Key Companies

Latest Interleukin-10 Pipeline Companies Update

AnaptysBio's ANB-038 Phase 2a trial for inflammatory bowel disease (IBD) met primary endpoint: December 2023 success paves the way for further clinical evaluation of ANB-038, a novel engineered IL-10 variant, for treating IBD.

Regeneron's REGN2810 Phase 2 trial for atopic dermatitis (AD) demonstrates positive preliminary data: January 2024 announcement suggests REGN2810's potential in treating AD, with improvements observed in itch and skin lesions.

Janssen Pharmaceutical's IL-10 antibody JNJ-75641378 in a Phase 2 trial for Sjögren's syndrome shows early efficacy: November 2023 development indicates potential for JNJ-75641378 in treating this autoimmune disease affecting salivary and tear glands.

AstraZeneca and Innate Pharma team up for IL-10-based immuno-oncology therapies: December 2023 collaboration combines expertise to develop next-generation IL-10 therapies for cancer treatment.

Roche and Evelo Biosciences partner to discover and develop novel IL-10 agonists: November 2023 collaboration leverages Evelo's AI-powered drug discovery platform to accelerate the development of new IL-10-based treatments.

List of Interleukin-10 Pipeline Key Companies in the Market

Pfizer Inc.

Merck & Co.Inc

Biotest AG

BioMAS Ltd

EnGene Inc.

Leo Pharma

Anvil Biosciences

Intrexon Corporation

P2D Biosciences

Xalud Therapeutics INC

Interleukin Market Highlights:

Interleukin Market Size

Interleukin Market Trends

Interleukin Market Analysis

Interleukin Market Share

Interleukin Market Highlights:

Interleukin Market Trends

Interleukin Market Analysis

Interleukin Market Share

Interleukin Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.